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Background: The increased plasma uric acid has been documented in ischemic cardiomyopathy (ICM) and
heart failure in other age ranges in human and in animal models. However, it remains incompletely clear
whether plasma uric acid is associated with cardiac remodeling, ischemic cardiomyopathy and heart failure
in elderly. So, the objective of the study was to investigate whether plasma uric acid was associated with
postinfarction cardiac remodeling in elderly with a previous myocardial infarction.
Methods: Data of 246 elderly aged 60 years and older with angiography-conﬁrmed coronary heart
disease and myocardial infarction were analyzed. Among the patients, 89 had ICM deﬁned as left
ventricular end-diastolic diameter [men > 55 mm, women > 50 mm (60.74 5.79 mm)] measured by
echocardiography. Difference in plasma uric acid was analyzed between patients with and without ICM.
Results: There was signiﬁcant increase in plasma uric acid in ICM compared with non-ICM
(444.66 160.97 umol/L vs. 372.59 131.31 umol/L, p¼ 0.000), and plasma uric acid was signiﬁcantly
positively related to left ventricular end-diastolic diameter (r¼ 0.312, p¼ 0.000).
Conclusions: Plasma uric acid is signiﬁcantly increased in elderly with ICM complicated with previous
myocardial infarction as well as with those elderly patients who have postinfarction cardiac remodeling
and previous myocardial infarction.
Copyright  2012, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Plasma uric acid increases signiﬁcantly in chronic heart failure1,
even though its mechanism remains unknown. It might be asso-
ciated with cardiorenal syndrome, a pathophysiologic condition in
which renal dysfunction might be secondary to heart failure and
combined dysfunction might amplify the failure of each2. The
decrease in uric acid renal excretion in the cardiorenal syndrome
could play a key role in the hyperuricemia in heart failure3. More-
over, our previous study has found that those elderly patients with
coronary heart disease silent myocardial ischemia and angina
pectoris complicated with ischemic cardiomyopathy (ICM) present
with signiﬁcantly increased plasma uric acid without renal dys-
funtion4. Thus, it seems reasonable to infer the link of increased
plasma uric acid to cardiac remodeling other than cardiorenalterest.
ology, Department of Geriat-
dical Univercity, Number 1
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iwan Society of Geriatric Emergensyndrome or renal dysfunction in ICM, neither of which might exist
in ICM. Peradventure the increased plasma uric acid in ICM might
be released from ischemic myocardium. To address this issue, we
collected the clinical data to evaluate the changes of plasma uric
acid, renal function, and their association with postinfarction
cardiac remodeling in elderly patients with ICM complicated with
coronary heart disease and previous myocardial infarction.2. Patients and methods
2.1. Patients
A total of 246 Chinese Han patients aged 60 years and older with
myocardial infarction risk factors, history, pathologic Q wave, or
primary ST-T wave changes during electrocardiography and one or
more of the coronary arteries with total occlusion or severe stenosis
(TIMI 0 ﬂow) with an angiogram-conﬁrmed coronary heart disease
with previous myocardial infarction were collected at the inpatient
department from January 2006 to December 2008 in our hospital
(165 men, 81 women). Their mean age was 74.28 7.72 years,
ranging from 60e97 years. According to the size of left ventricularcy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
Table 1
Comparison of clinical characteristics between ICM and non-ICM groups.a
Variable ICM (n¼ 89) Non-ICM
(n¼ 157)
F value p value
Sex (men/women, n) 59/30 106/51 0.038 0.845
Age (yr) 72.96 6.36 75.03 8.33 4.134 0.053
BMI (kg/m2) 22.12 2.15 21.92 2.08 2.560 0.107
MI history (yr) 4.53 5.97 3.50 4.27 2.446 0.119
Q/non-Q wave (n) 89/0 154/3 3.056 0.099
Anterior/inferior (n) 52/37 87/70 0.326 0.568
HR (beats/minute) 83.57 19.50 83.47 20.23 0.002 0.968
SBP (mmHg) 134.36 24.91 136.80 29.28 0.437 0.509
DBP (mmHg) 79.71 15.77 76.64 14.70 2.350 0.127
Fasting glucose (mmol/L) 6.62 2.08 7.03 3.06 0.878 0.350
TC (mmol/L) 4.21 1.05 4.20 1.14 0.003 0.958
LDL-C (mmol/L) 2.50 0.85 2.37 0.96 0.791 0.375
HDL-C (mmol/L) 1.11 0.40 1.12 0.29 0.086 0.769
TG (mmol/L) 1.22 0.49 1.32 0.74 1.132 0.289
Creatinine (umol/L) 116.44 63.30 119.49 106.28 0.058 0.810
Urea nitrogen (mmol/L) 8.34 5.09 8.58 6.84 0.074 0.786
eGFR (ml.min1.1.73 m2) 77.33 28.68 81.76 31.37 1.144 0.286
LVDd (mm) 60.74 5.79 47.55 4.42 241.839 0.000
LVDs (mm) 45.68 7.08 32.00 4.08 212.315 0.000
LA (mm) 36.51 5.10 31.26 5.24 36.802 0.000
RV (mm) 21.22 3.05 19.03 2.69 20.749 0.000
LVEF (%) 47.63 10.54 59.17 10.61 42.709 0.000
Class (NYHA) 2.14 0.99 1.23 0.48 90.055 0.000
BMI¼ body mass index; DBP¼ diastolic blood pressure; eGFR¼ estimated
glomerular ﬁltration rate; HDL-C¼ high-density lipoprotein cholesterol; HR¼ heart
rate; ICM¼ ischemic cardiomyopathy; LA¼ left atrial diameter; LDL-C¼ low-
density lipoprotein cholesterol; LVDd¼ left ventricular end-diastolic diameter;
LVDs¼ left ventricular end-systolic diameter; LVEF¼ left ventricular ejection frac-
tion; MI¼myocardial infarction; NYHA¼New York Heart Association; RV¼ right
ventricular diameter; SEM¼ standard error of mean; SBP¼ systolic blood pressure;
TC¼ total cholesterol; TG¼ triglycerides.
a Data are mean SEM.
Fig. 1. Plasma uric acid was signiﬁcantly positively related to left ventricular end-
diastolic diameter.
Plasma Uric Acid in Elderly Pts with MI 175end-diastolic diameter (LVDd) measured by M-mode echocardi-
ography, the patients were classiﬁed into the ICM group [n¼ 89,
with LVDd men > 55 mm, women > 50 mm (60.74 5.79 mm)]4,5
and the non-ICM group [n¼ 157, with LVDd men  55 mm, women
 50 mm (47.55 4.42 mm)].
Exclusion criteria included ICM resulting from coronary heart
disease, with acute myocardial infarction, silent myocardial
ischemia and angina pectoris, and primary cardiomyopathy and
other secondary cardiomyopathies such as those from valvular
heart diseases.
The study received consent from the ethic committee of
Chongqing Medical University, Chongqing, China.
2.2. Variables
On admission, blood samples were collected after an overnight
fasting at the clinical biochemical laboratory in our hospital. The
following parameters were determined: plasma uric acid, creati-
nine, and urea nitrogen concentration. Estimated glomerular
ﬁltration (eGFR) was (rate, ml.min1.1.73 m2) 186.3 [plasma
creatinine (mg/dl)]1.154 [age (year)]0.2031.233 (if Chinese)
0.742 (if female)6.
2.3. Statistical analysis
SPSS 10.0 software package (IBM company, Chicago, Illinois
60606, USA) was employed for statistical analysis. All parameters
are expressed as mean standard deviation. One-way analysis of
variance and Pearson correlation were utilized for measurement
data analysis and independent association analysis. A p value of
< 0.05 was considered signiﬁcant.
3. Results
3.1. Clinical features between ICM and non-ICM group
As compared with the non-ICM group, cases with ICM presented
with signiﬁcantly increased LVDd, left ventricular end-systolic
diameter (LVDs), left atrial diameter, right ventricular diameter,
and cardiac functional class per the New York Heart Association
classiﬁcation, but had signiﬁcantly decreased left ventricular ejec-
tion fraction (LVEF). All were p¼ 0.000, and this is shown in Table 1.
The result supports the diagnosis of ICM based on remarkable
cardiac remodeling and heart failure in the ICM group. By contrast,
no signiﬁcant difference in age, sex, body mass index, acute
myocardial infarction history, infarction site, infarctionwith Q wave,
heart rate, primary hypertension, type 2 diabetes, stroke, systolic
blood pressure, diastolic blood pressure, plasma fast blood glucose,
total cholesterol low-density lipoprotein cholesterol, high-density
lipoprotein cholesterol triglycerides, creatinine, urea nitrogen, or
eGFR could be found between the two groups (All p> 0.05). This is
shown in Table 1. The parameters are comparable between the ICM
and non-ICM groups with uric acid as an exception.
In the study, 49.44% patients were treated with digitalis
(f¼ 31.490, p¼ 0.000), 70.79% with diuretics (f¼ 28.361, p¼ 0.000),
hydrochlorothiazide 8.849 0.781 mg (f¼ 89.614, p¼ 0.000),
furosemide 3.540 0.323 mg (f¼ 93.501, p¼ 0.000), 69.66% with
b1 blocker (f¼ 4.492, p¼ 0.035), 88.76% with ACEI/ARB (f¼ 11.607,
p¼ 0.001), 68.54% with nitrates (f¼ 0.875, p¼ 0.350), and 20.23%
with calcium channel blocker (f¼ 1.987, p¼ 0.160) in the ICM
group; while a total of 17.20% patients were treated with digitalis,
36.94% with diuretics, hydrochlorothiazide 4.618 0.285 mg,
furosemide 1.2310.095 mg, 56.05% with b1 blocker, 66.24% with
ACEI/ARB, 61.78% with nitrates, and 28.03% with calcium channel
blocker in the non-ICM group.3.2. Comparison of plasma uric acid between ICM and
non-ICM groups
There was signiﬁcant increase in plasma uric acid in the ICM
group (432.82143.05 umol/L, f¼ 13.745, p¼ 0.000) compared
with the non-ICM group (361.06137.35 umol/L); plasma uric acid
was signiﬁcantly positively related to LVDd (r¼ 0.312, p¼ 0.000).
This is shown in Fig. 1.
4. Discussion
Our present study demonstrated that there was signiﬁcantly
increased plasma uric acid, and no signiﬁcant change in eGFR in
ICM complicated by previous myocardial infarction; plasma uric
acid was also found to be signiﬁcantly and positively correlated
with LVDd. However, no correlation was found between eGFR and
LVDd in ICM complicated by previous myocardial infarction. These
ﬁndings above implied the positive association of plasma uric acid
level with postinfarction cardiac remodeling other than with renal
G. Li et al.176dysfunction or cardiorenal syndrome, and the increased plasma
uric acid in ICM complicated with previous myocardial infarction
might be ascribed to the overproduction of uric acid by the
ischemic myocardium around the infarcted zones but not from
renal dysfunction or cardiorenal syndrome.
The activated xanthine oxydase and its following increased
synthesis of uric acid and their associations withmechanoenergetic
uncoupling in failing heart has been conﬁrmed7,8. Inhibition of
xanthine oxidase and uric acid synthesis in ischemic myocardium
around the infarcted zones can improve the cardiac function and
survival in postinfarction by improvingmechanoenergetic coupling
in animal studies9,10. Plasma uric acid could be very helpful for the
diagnosis1,11 and prognosis evaluation in heart failure in human
studies12,13. All the ﬁndings above make it reasonable to infer that
the increased plasma uric acid in ICM complicated with previous
myocardial infarction in the present study could result from the
overproduction of uric acid by the ischemic myocardium around
the infarcted zones. The mechanisms under which the peri-
infarction myocardium overproduces uric acid could be reasoned
from activated xanthine oxydase in cardiomyocytes and vascular
endothelia in ischemic myocardium around the infarcted zones.
Plasma uric acid could also be very helpful for the diagnosis,
prognosis evaluation, and treatment efﬁciency in elderly patients
with postinfarction cardiac remodeling, ICM, and heart failure. The
result was consistent with our previous ﬁndings4 and similar
ﬁndings reported elsewhere1,12,13. The association of increased
plasma uric acid with postinfarction cardiac remodeling in ICM
could also be found in the report from Sakai and colleagues12. No
signiﬁcant association has been found between renal and cardiac
dysfunction, even though both renal and cardiac dysfunction could
predict mortality independently14,15. Similar to the previous ﬁnd-
ings14,15, we could not ﬁnd any evidence of renal dysfunction or
cardiorenal syndrome in complicated ICM with previous myocar-
dial infarction, arguing against their associationwith postinfarction
cardiac remodeling. And as a result, the increased plasma uric acid
in patients with ICM complicated by previous myocardial infarction
could be ascribed rather to the overproduction from ischemic
myocardium around the infarcted zones than to renal dysfunction
or cardiorenal syndrome.
Serum uric acid has been found to be signiﬁcantly higher in the
coronary sinus than in the aortic root in heart failure, and its level
varies inversely with LVEF and positively LVED volume index. This
ﬁnding implied the association of hyperuricemia with failing heart
but not from the diuretics in heart failure12. Similarly, it seems
reasonable to ascribe the increased plasma uric acid in ICM compli-
catedwith previousmyocardial infarction in the present study to the
ischemic myocardium around the infarcted zones. By contrast, the
use of diuretics should not be the only reason for the hyperuricemia
in ICM, since relatively low dose of diuretics were used in this
study16,17. On the other hand, a further study using catheterization
would be necessary to address this issue. Another limit to this study
was its retrospective design and relatively small sample size.
In summary, plasma uric acid is signiﬁcantly increased in elderly
patients with ICM complicated with previous myocardial infarction.Plasma uric acid is thought to be associated with postinfarction
cardiac remodeling in elderly patients with previous myocardial
infarction.
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